Back
ProMIS Neurosciences, Inc. 10K Form
Sell
13
PMN
ProMIS Neurosciences, Inc.
Last Price:
$8.05
Seasonality Move:
5.53%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PMN News And Ratings
See the #1 stock for the next 7 days that we like better than PMN
PMN Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-10.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.27 |
| Price / Book: | 2 |
Profitability
| EPS (TTM): | -13.57840 |
|---|---|
| Net Income (TTM): | $-29.3M |
| Gross Margin: | $0 |
| Return on Equity: | -348.3% |
| Return on Assets: | -166.31% |
ProMIS Neurosciences, Inc. Earnings Forecast
Key ProMIS Neurosciences, Inc. Financial Ratios
-
The Interest Expense is 2.76% of Operating Income.
-
Per Share Earnings over the last 20 years have been positive in 12 years.
ProMIS Neurosciences, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PMN |
| Website: | promisneurosciences.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 1.76 |
| Quick Ratio: | 1.26 |
Price-to-Earnings
| Trailing P/E Ratio: | 3.26 |
|---|---|
| Forward P/E Ratio: | 0 |
PMN Technical Analysis vs Fundamental Analysis
Sell
13
ProMIS Neurosciences, Inc. (PMN)
is a Sell
Is ProMIS Neurosciences, Inc. a Buy or a Sell?
-
ProMIS Neurosciences, Inc. stock is rated a SellThe current ProMIS Neurosciences, Inc. [PMN] share price is $8.55. The Score for PMN is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.